Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study.Lancet. 2004; 364: 2097-2105
- Survival of European children and young adults with cancer diagnosed 1995–2002.Eur J Cancer. 2009; 45: 992-1005
- Clinical trials for children with cancer in Europe – still a long way from harmonisation: a report from SIOP Europe.Eur J Cancer. 2008; 44: 2106-2111
- Cancer in children and adolescents in Europe: developments over 20 years and future challenges.Eur J Cancer. 2006; 42: 2183-2190
- Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries.Lancet Oncol. 2013; 14: e95-e103
- Report on ‘the standards in paediatric oncology’.SIOPE Newsl. 2009; 4 (http://www.siope.eu/binarydata.aspx?type=doc/Newsletter_FEBR_2009.pdf)
Report from conference: European Standards of Care for Children with Cancer. SIOPE Newsl 2011;11:5–7. http://www.siope.eu/binarydata.aspx?type=doc/FINAL_V_DEC_2011.pdf.
- New policies to address the global burden of childhood cancers.Lancet Oncol. 2013; 14: e125-e135
European Standards of Care for Children with Cancer. http://www.siope.eu/binarydata.aspx?type=doc/European_Standards_final_2011.pdf.
- Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.Pediatr Blood Cancer. 2012; 58: 334-343
- The state of research into children with cancer across Europe: new policies for a new decade.eCancer. 2011; 5: 210
- Will children with cancer benefit from the new European Paediatric Medicines Regulation?.Eur J Cancer. 2009; 45: 1535-1546
☆This publication arises from the European Partnership for Action Against Cancer, which has received funding from the European Union, in the framework of the Health Programme.